CN Patent

CN115304591B — 一种桥环甾体合成酶抑制剂及其制备方法和应用

Assigned to Guangzhou University of Traditional Chinese Medicine · Expires 2024-10-01 · 2y expired

What this patent protects

本发明公开了一种桥环甾体合成酶抑制剂及其制备方法和应用，属于医药技术领域。本发明提供了一种可作为药物的化合物，其具有抑制甾体合成酶的作用，且抑制率高，可以用来制备治疗激素依赖型疾病的药物。

USPTO Abstract

本发明公开了一种桥环甾体合成酶抑制剂及其制备方法和应用，属于医药技术领域。本发明提供了一种可作为药物的化合物，其具有抑制甾体合成酶的作用，且抑制率高，可以用来制备治疗激素依赖型疾病的药物。

Drugs covered by this patent

osilodrostat-phosphate (OSILODROSTAT PHOSPHATE)

Patent Metadata

Patent number: CN115304591B
Jurisdiction: CN
Classification: —
Expires: 2024-10-01
Drug substance claim: No
Drug product claim: No
Assignee: Guangzhou University of Traditional Chinese Medicine
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.